Stockholm, Sweden. Wellma, a leading European development and production partner in the nutraceutical and pharmaceutical sectors, announces its strategic partnership with PlantaCorp, a German CDMO and leading innovator in liposomal technology for liquid formulations.

Based in Hamburg, Germany, PlantaCorp is known for its cutting-edge R&D and proprietary liposomal encapsulation technology, which enhances the bioavailability of active ingredients. Liposomal formulations improve nutrient absorption by protecting the active compounds in phospholipid layers, allowing for higher efficacy and better outcomes for the consumer. With a strong scientific foundation, a commitment to quality, and advanced manufacturing operations, PlantaCorp has built a reputation as a trusted partner for brands in the nutraceutical sector.

“We are excited about the opportunities this partnership will bring,” said Jan Braband, co-founder and CEO at PlantaCorp. “By joining forces with Wellma, we can expand our reach, accelerate innovation, and team up to be able to grow even faster while we create even more value for our customers.”
The partnership also represents an alignment of personal values and entrepreneurial culture, as Rinat Albetkov, co-founder of PlantaCorp, highlights the strong cultural and strategic fit: “From our first conversations with Wellma, we saw a shared vision for innovation, people, entrepreneurship and sustainable growth. This partnership ensures that our technology, expertise, and entrepreneurial culture continue to thrive while also opening up exciting new opportunities for us.”

Christian Merup, CEO of Wellma, shares the excitement: “We are delighted to welcome PlantaCorp into the Wellma family. From the very beginning, we have been impressed by their advanced R&D expertise, their vision, and their strong entrepreneurial capabilities — all of which align perfectly with Wellma’s vision. Jan and Rinat perfectly represent entrepreneurship, deep expertise, willingness to grow and high focus on innovation & quality. The whole Wellma team looks forward to teaming up with them and the entire PlantaCorp team to continue driving innovation and excellence for our customers. This is a great addition for Wellma, bringing new capabilities and opening many areas for collaboration that will make us all stronger: 1+1 >3. We look forward to the future together”.

The alliance with PlantaCorp further strengthens Wellma’s position as European leader in the development and production of nutraceuticals and pharmaceuticals, by uniting top entrepreneurial companies to offer advanced capabilities and high-quality products to its customers.

About Wellma: Wellma is a European leader in development and production of nutraceuticals and pharmaceuticals with production sites across the European continent, a global customer base, and fast-growing with €120M+ in sales. With focus on quality, flexibility and innovation, Wellma offers B2B development and production services to leading actors in the nutraceutical and pharmaceutical space.

About PlantaCorp: PlantaCorp is a leading German-based R&D and manufacturing company specialized on liposomal technology in liquid form, offering B2B nutraceutical customers the technology and expertise to create their own high-bioavailability liposomal formulations. With a commitment to advanced research, quality, and cutting-edge production, PlantaCorp helps brands deliver effective and scientifically validated products to consumers.

For media inquiries or further information, please contact: michael@wellma.com